6,11-bridged erythromycin derivatives

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 17/00 (2006.01) A61K 31/70 (2006.01) C07H 17/08 (2006.01)

Patent

CA 2307828

Novel 6,11-bridged erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I) or (II); compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier; a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention; and processes for their preparation.

La présente invention concerne, d'une part des composés d'érythromycine à pont 6,11, d'autre part certains de leurs sels pharmaceutiquement admis de ces composés, et aussi des esters de ces sels présentant une activité antibactérienne, tous pouvant être représentés par la formule générale (I) ou (II). L'invention concerne également des compositions comprenant une quantité thérapeutiquement efficace d'un composé de l'invention en association avec un excipient ou vecteur pharmaceutiquement admis. L'invention concerne aussi un traitement dirigé contre des infections bactériennes et consistant en l'administration, à un mammifère, d'une composition pharmaceutique comprenant une quantité thérapeutiquement efficace d'un composé de l'invention. L'invention concerne enfin les procédés de préparation correspondants.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

6,11-bridged erythromycin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 6,11-bridged erythromycin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6,11-bridged erythromycin derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1674674

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.